Stephen C. Lim
A5102013854- COVID-19 and Mental Health
- COVID-19 and healthcare impacts
- Long-Term Effects of COVID-19
- SARS-CoV-2 and COVID-19 Research
- COVID-19 epidemiological studies
- COVID-19 Clinical Research Studies
- Vaccine Coverage and Hesitancy
- Healthcare professionals’ stress and burnout
- SARS-CoV-2 detection and testing
- COVID-19 diagnosis using AI
- Infection Control and Ventilation
- Parasitic Diseases Research and Treatment
- Pharmacological Receptor Mechanisms and Effects
- Viral gastroenteritis research and epidemiology
- Electroconvulsive Therapy Studies
- Respiratory viral infections research
- Viral Infections and Outbreaks Research
- COVID-19 Impact on Reproduction
- Epilepsy research and treatment
- Foreign Body Medical Cases
- Influenza Virus Research Studies
- Zoonotic diseases and public health
- Restraint-Related Deaths
- Disaster Response and Management
- Parasites and Host Interactions
Institute of Accelerating Systems and Applications
2022-2024
Louisiana State University Health Sciences Center New Orleans
2019-2023
University Medical Center New Orleans
2020-2023
Universidade Estadual de Campinas (UNICAMP)
2022
Université de Bordeaux
2022
Niigata University
2022
University of Cagliari
2022
University of L'Aquila
2022
Korea Research Institute of Chemical Technology
2022
Yeungnam University
2022
Throughout the COVID-19 pandemic, health care personnel (HCP) have been at high risk for exposure to SARS-CoV-2, virus that causes COVID-19, through patient interactions and community (1). The Advisory Committee on Immunization Practices recommended prioritization of HCP vaccination maintain provision critical services reduce spread infection in settings (2). Early distribution two mRNA vaccines (Pfizer-BioNTech Moderna) allowed assessment effectiveness these a real-world setting. A...
BackgroundThe prioritization of U.S. health care personnel for early receipt messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes disease 2019 (Covid-19), allowed evaluation effectiveness these new in a real-world setting.MethodsWe conducted test-negative case–control study involving across 25 states. Cases were defined on basis positive polymerase-chain-reaction (PCR) or antigen-based test SARS-CoV-2 and at least one...
The objective was to assess anxiety and burnout levels, home life changes, measures relieve stress of U.S. academic emergency medicine (EM) physicians during the COVID-19 pandemic acceleration phase.
It is unknown whether ivermectin, with a maximum targeted dose of 600 μg/kg, shortens symptom duration or prevents hospitalization among outpatients mild to moderate COVID-19.
The effect of higher-dose fluvoxamine in reducing symptom duration among outpatients with mild to moderate COVID-19 remains uncertain.
Abstract Objectives The objective was to provide a longitudinal assessment of anxiety levels and work home concerns U.S. emergency physicians during the COVID‐19 pandemic. Methods We performed longitudinal, cross‐sectional email survey clinically active (attending, fellow, resident) at seven academic departments. Follow‐up surveys were sent 4 6 weeks after initial assessed following: patient exposure, availability testing, workplace anxiety/stress, changes in behaviors, performance on...
Bivalent mRNA vaccines were recommended since September 2022. However, coverage with a recent vaccine dose has been limited, and there are few robust estimates of bivalent VE against symptomatic SARS-CoV-2 infection (COVID-19). We estimated COVID-19 among eligible U.S. healthcare personnel who had previously received monovalent doses.
Objectives Accurate and reliable criteria to rapidly estimate the probability of infection with novel coronavirus-2 that causes severe acute respiratory syndrome (SARS-CoV-2) associated disease (COVID-19) remain an urgent unmet need, especially in emergency care. The objective was derive validate a clinical prediction score for SARS-CoV-2 uses simple widely available at point Methods Data came from registry data national REgistry suspected COVID-19 EmeRgency care (RECOVER network) comprising...
Abstract Background Protection against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (coronavirus disease 2019 [COVID-19]) can limit transmission and the risk of post-COVID conditions, is particularly important among healthcare personnel. However, lower vaccine effectiveness (VE) has been reported since predominance Omicron SARS-CoV-2 variant. Methods We evaluated VE a monovalent messenger RNA (mRNA) booster dose COVID-19 from October 2021 to June 2022 US...
Importance Access to COVID-19 testing is critical reducing transmission and supporting early treatment decisions; when made accessible, the timeliness of may also be an important metric in mitigating community spread infection. While disparities outcomes have been well documented, extent association with demographic factors unclear. Objectives To evaluate associated delayed among health care personnel (HCP) during pandemic. Design, Setting, Participants This cross-sectional study used data...
Objectives The COVID-19 pandemic has required significant modifications of hospital care. objective this study was to examine the operational approaches taken by US hospitals over time in response pandemic. Design, setting and participants This a prospective observational 17 geographically diverse from February 2020 2021. Outcomes analysis We identified 42 potential pandemic-related strategies obtained week-to-week data about their use. calculated descriptive statistics for use each strategy...
Abstract Background Whether ivermectin, with a maximum targeted dose of 600 μg/kg, shortens symptom duration or prevents hospitalization among outpatients mild to moderate coronavirus disease 2019 (COVID-19) remains unknown. Our objective was evaluate the effectiveness dosed at daily for 6 days compared placebo treatment early COVID-19. Methods ACTIV-6, an ongoing, decentralized, randomized, double-blind, placebo-controlled, platform trial, designed repurposed therapies in A total 1206...
Abstract Background The objective of this study was to test the hypothesis that subsequent doses coronavirus disease 2019 (COVID-19) vaccine are associated with lower incidence COVID-19-like symptoms at 6 weeks after infection. Methods This a case–control analysis health care personnel in an ongoing multicenter COVID-19 effectiveness study. We enrolled participants time between December 19, 2021, and April 27, 2022, which corresponded early Omicron-predominant period original monovalent...
Abstract Objectives Accurate and reliable criteria to rapidly estimate the probability of infection with novel coronavirus-2 that causes severe acute respiratory syndrome (SARS-CoV-2) associated disease (COVID-19) remain an urgent unmet need, especially in emergency care. The objective was derive validate a clinical prediction rule for SARS-CoV-2 uses simple widely available at point Methods Data came from Registry data national REgistry suspected COVID-19 EmeRgency care (RECOVER network)...
The French society of clinical biology "Biochemical markers COVID-19" has set up a working group with the primary aim reviewing, analyzing and monitoring evolution biological prescriptions according to patient's care path look for progression severity disease.This study covers all public private sectors medical located in metropolitan overseas France also extends French-speaking world.This article presents testimonies data obtained "Overseas countries" sub-working made 45 volunteer...
Facemask use is associated with reduced transmission of SARS-CoV-2. Most surveys assessing perceptions and practices mask miss the most vulnerable racial, ethnic, socio-economic populations. These same populations have suffered disproportionate impacts from pandemic. The purpose this study was to assess beliefs, access, wearing across 15 urban emergency department (ED) populations.This a secondary analysis cross-sectional ED patients December 2020 March 2021 at geographically diverse, safety...